cancer
Bayer asks appeals court to toss ‘speculative’ $25 million glyphosate-cancer verdict
Bayer AG on [Dec. 16] said it has asked a U.S. federal appeals court to throw out a $25 million ...
Viewpoint: How the glyphosate-cancer controversy became a moral crusade—and a threat to scientific progress
Sometimes the clear weight of evidence coupled with a dose of common sense is enough to show what’s right ...
Viewpoint: Regulatory hurdles keep life-saving, plant-made vaccines off the market
Plant-made vaccines have been in the pipeline for nearly thirty years. Generated stably in transgenic plants or transiently using virus ...
Glyphosate-cancer trials postponed while Bayer, plaintiffs negotiate potential $8-$12 billion settlement
Germany’s Bayer has agreed with plaintiffs to postpone its next two U.S. lawsuits over the alleged cancer-causing effects of its ...
Aggressive cancer adapts quickly thanks to odd ‘doughnut-shaped’ DNA
Cancer cells may owe some of their destructive nature to unique, "doughnut-shaped" DNA, according to a new study. The study, published ...
Why the quest to ‘cure’ cancer may be destined to fail
Many of the risk factors to do with cancer are related to lifestyle, so there is concrete action people can ...
Drug cocktail shows promise against pancreatic cancer, highlighting potential of combined treatments
Researchers led by a team at Sanford Burnham Prebys Medical Discovery Institute have identified a combination of two already approved ...
Cancer cells alter mutation rates to survive targeted therapies. Researchers want to know how they do it.
In response to antibiotic treatment, bacteria improve their odds of survival by increasing the rate of mutations in their genomes, ...
Bayer faces $500 million Monsanto glyphosate-cancer class action suit in Canada
Toronto-based law firm Diamond & Diamond is spearheading a $500 million class action lawsuit against various Roundup makers, including pharmaceutical ...
Expensive CAR-T therapy raises difficult question: ‘What is the price of a human life?’
A new type of therapy for certain blood cancers is ingenious but it raises important questions about its cost, both ...
Are highly educated people more likely to get cancer? Or just more likely to get tested?
A person’s socioeconomic status plays a role in the type of cancer they might get, the Cancer Registry researchers found ...
Podcast: Epidemiologist Geoffrey Kabat explains how junk science gets published—and how to spot it in the headlines
Bad research can put people's lives at risk, so addressing problems with peer review is essential ...
Podcast: CRISPR advances, HIV cures and a perfect predator for superbugs
Exploring the latest advances in medical biotechnology including CRISPR-based gene therapies, infection-fighting viruses and a cure for HIV. Plus reflections ...
Podcast: Can we ‘outsmart’ cancer with synthetic biology? Dr. Tim Lu talks customized disease treatments
On this episode of Biotech Facts and Fallacies, Tim Lu talks to Cameron English about Senti's progress toward "outsmarting complex ...
Podcast: Genetically engineered CAR-T cell therapies destroy cancer cells. Here’s how they work
Many millions of words have been written about GMO crops. As a result, most people know they can now buy ...
If we aren’t careful, we could miss the chance to learn cancer-fighting secrets from threatened whales and elephants
The loss of vulnerable mammals means scientists could miss out on useful quirks in their genetics ...
Glyphosate-cancer lawsuit tally doubles to 42,700, as settlement talks attract more plaintiffs, Bayer says
Germany’s Bayer is now facing 42,700 U.S. plaintiffs blaming its glyphosate-based weedkillers for their cancer, more than twice the tally ...
Video: Two mutations join forces to create deadlier cancer
Sometimes the whole is greater than the sum of its parts. Researchers at Cold Spring Harbor Laboratory have discovered that ...
Canadian contractor alleges glyphosate caused his cancer in new suit against Bayer
[Cliff] Sissons, a 57-year-old man from Cranbrook, B.C., is trying to stay positive after a battle with non-Hodgkin’s lymphoma. He ...
Bayer could face over 45,000 glyphosate-cancer cases as settlement talks continue
Bayer expects the number of claims in the United States related to Roundup herbicide to have surged in the third ...
Personalizing pancreatic cancer treatment by growing, treating tumors in a dish
Only about 15% of advanced pancreatic patients are alive two years after their diagnosis. Margaret Schwarzhans has now made it ...
Blaming overdiagnosis of cancer on ‘irrational exuberance’: Are we too concerned about early detection?
Even though overall mortality from cancer is falling, the overall incidence is rising. The declines in lung, stomach, cervical, and ...
‘Why didn’t we think of this earlier?’ Immunotherapy could treat more than just cancer
Immunotherapy has transformed cancer care. Now the tools and new knowledge created by this strategy for treating disease by stimulating ...
October glyphosate-cancer trial delayed as settlement negotiations continue, Bayer says
A pending U.S. lawsuit over claims related to Bayer’s (BAYGn.DE) glyphosate-based herbicide Roundup has been delayed, the company said on ...
‘It’s unsettling’: Cancer cells use the body’s nerves to attack the brain, studies suggest
Tumour cells can plug into—and feed off—the brain’s complex network of neurons, according to a trio of studies. This nefarious ...
Podcast: How ‘activist science’ behind IARC’s glyphosate assessment fuels unjustified cancer lawsuits
In 2015, the International Agency for Research on Cancer (IARC) published a monograph concluding that glyphosate, the active ingredient in ...
Ticking time bomb: Being obese ‘more than doubles’ risk of common forms of cancer
Being overweight or obese has been linked to at least 13 types of cancer. Obesity more than doubles the risk ...
